NCT02826330View on ClinicalTrials.gov

Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

October 3, 2013

Primary Completion Date

April 3, 2019

Study Completion Date

April 3, 2019

Conditions
Crohn's DiseaseGenetic Predisposition
Interventions
OTHER

biomarkers

fecal microbiota analysis antibodies in serum and saliva DNA polymorphisms

Trial Locations (10)

54000

Nancy University Hospital, Nancy

63000

cLERMONT fERRAND University Hospital, Clermont-Ferrand

75000

Aphp Necker, Paris

APHP Robert Debré, Paris

Aphp St Antoine, Paris

76000

Rouen University Hospital, Rouen

80000

Amiens University & Hospital, Amiens

Unknown

APHP Kremlin Bicêtre, Le Kremlin-Bicêtre

CHRU,Hôpital Jeanne de Flandres, Lille

Hôpital Claude Huriez, CHRU, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT02826330 - Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease | Biotech Hunter | Biotech Hunter